香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明,，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED （於香港註冊成立的有限公司） （股份代號:2666） 本集團未經審核二零二五年第三季度營運概要 專科醫療及健康科技方面，本集團圍繞核心醫療資源，堅持內涵式發展與外延式擴張「雙 輪驅動」，培育特色業務及核心能力，努力打造第二增長曲線。當前，此版塊在佈局拓展、 能力建設等方面已陸續取得進展，相關併購項目也在順利推進中。 通用環球醫療集團有限公司 本公告載列通用環球醫療集團有限公司（「本公司」或「環球醫療」）及其附屬公司 （「本集團」）截至二零二五年九月三十日止第三季度未經審核之營運概要。 本公告為根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及 香港法例第571章證券及期貨條例第XIVA部內幕消息條文（定義見上市規則）作出。 二零二五年前三季度，本集團整體經營穩中向好，各項重 ...

Core Points - The company announced the issuance of the third phase of its 2025 renewable corporate bonds by its wholly-owned subsidiary, China Global Leasing Co., Ltd [1] - The total principal amount of the bonds issued is RMB 300 million, with a fixed interest rate of 2.05% [1] - The bonds were successfully issued in China on October 28, 2025, with a basic term of 1 year [1] - The issuer has the right to exercise the renewal option at the end of the basic term and at the end of each renewal period [1] - The issuance price of the bonds is RMB 100 per bond, equivalent to 100% of the face value [1]

Core Viewpoint - The company announced the issuance of its third phase of renewable corporate bonds for 2025, totaling RMB 300 million, with a fixed interest rate of 2.05% [1] Group 1: Bond Issuance Details - The bonds were issued by the company's wholly-owned subsidiary, China Global Leasing Co., Ltd., within China [1] - The total principal amount of the bonds issued is RMB 300 million, with a base term of 1 year starting from October 28, 2025 [1] - The issuance price is set at RMB 100 per bond, equivalent to 100% of the bond's face value [1] Group 2: Terms and Conditions - The issuer has the right to exercise the renewal option at the end of the base term and at the end of each renewal cycle [1] - The fixed interest rate for the bonds is 2.05% [1]

Core Viewpoint - Global Medical (02666.HK) has issued the third phase of its 2025 renewable corporate bonds in China, totaling RMB 300 million with a fixed interest rate of 2.05% [1] Group 1: Bond Issuance Details - The total principal amount of the bonds issued is RMB 300 million [1] - The bonds have a base term of 1 year starting from October 28, 2025 [1] - The issuance price is set at RMB 100 per bond, equivalent to the face value of the bonds [1] Group 2: Renewal Option - The issuer has the right to exercise a renewal option at the end of the base term and at the end of each renewal cycle [1]

通用環球醫療集團有限公司 GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED （於香港註冊成立的有限公司） (股份代號：2666) 本公司全資附屬公司中國環球租賃有限公司 完成二零二五年第三期可續期公司債券發行 本公告乃由通用環球醫療集團有限公司（「本公司」）根據香港聯合交易所有限公司證券上 市規則（「上市規則」）第13.09(2)(a)條及香港法例第571章證券及期貨條例第XIVA部內幕 消息條文（定義見上市規則）作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承 擔任何責任。 1 承董事會命 通用環球醫療集團有限公司 Genertec Universal Medical Group Company Limited 陳仕俗 董事會主席 中國北京， 二零二五年十月二十八日 於本公告日期，本公司的執行董事為陳仕俗先生（主席）、王文兵先生及王琳女士；本公司的非執行董事為童 朝銀先生、林春海先生及朱梓陽先生；而本公司的獨 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 （股份代號：2666） 持續關連交易 修訂 2024 年醫療相關產品採購框架協議、 2024 年醫療相關產品銷售框架協議 及 2024 年物業租賃框架協議項下的年度上限 GENERTE CUNIVERSAL MEDICAL GROUP COMPANY LIMITED （於香港註冊成立的有限公司） 通用環球醫療集團有限公司 修訂2024年醫療相關產品採購框架協議項下的年度上限 茲提述本公司日期為 2023 年 11 月 23 日的公告，内容有關（其中包括）2024 年醫療相關 產品採購框架協議項下的持續關連交易及其年度上限。2023 年 11 月 23 日，本公司與通用 技術集團訂立 2024 年醫療相關產品採購框架協議，據此，本公司及╱或其附屬公司將向 通用技術集團及╱或其聯繫人採購醫療相關產品以及配套物流及倉儲服務。 鑒於截至2025年12月31日及2026年12月31日止兩個年度的現有年度上限預期不 ...

Core Viewpoint - The company, Global Medical (02666), has received approval from the China Securities Regulatory Commission (CSRC) to issue a maximum of 2 billion RMB in domestic perpetual corporate bonds aimed at qualified investors, with a remaining quota of 650 million RMB as of the announcement date [1] Summary by Sections - **Bond Issuance Details** - The bond will be issued in tranches, with the current issuance amount not exceeding 300 million RMB (including 300 million RMB) [1] - The face value of the bond is set at 100 RMB, and the issuance price is also 100 RMB [1] - The expected start date for the offline issuance of this corporate bond is October 24, 2025 [1]

Core Viewpoint - The company, Universal Medical (02666), has received approval from the China Securities Regulatory Commission (CSRC) to issue a maximum of 2 billion RMB in domestic perpetual corporate bonds aimed at qualified investors, with a remaining quota of 650 million RMB as of the announcement date [1] Group 1 - The company's wholly-owned subsidiary, China Universal Leasing Co., Ltd., is the issuer of the bonds [1] - The bonds will be issued in tranches, with the current issuance amount not exceeding 300 million RMB [1] - The face value of the bonds is set at 100 RMB, with an issuance price also at 100 RMB [1] Group 2 - The expected start date for the offline issuance of these corporate bonds is October 24, 2025 [1]

Core Viewpoint - The company, Global Medical (02666.HK), has received approval from the China Securities Regulatory Commission to publicly issue a maximum of RMB 2 billion in domestic renewable corporate bonds aimed at qualified investors, with a remaining quota of RMB 650 million as of the announcement date [1] Group 1 - The bond issuance will be conducted in tranches, with the total principal amount for this issuance not exceeding RMB 300 million [1] - The basic term of the corporate bond is set at 1 year, with the issuer having the option to extend the term by one repricing cycle or fully redeem the bond at the end of the basic term and each repricing cycle [1] - The bond includes options for the issuer to renew, defer interest payments, and redeem, with a fixed interest rate for the first cycle determined through a book-building process [1] Group 2 - The interest rate for subsequent cycles will be adjusted to the current benchmark rate plus the initial spread plus an additional 300 basis points [1] - The net proceeds from this bond issuance will be used by the issuer to supplement operational funds [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承 擔任何責任。 通用環球醫療集團有限公司 GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED （於香港註冊成立的有限公司） （股份代號：2666） 有關本公司的全資附屬公司 於中國境內公開發行二零二五年第三期可續期公司債券的公告 本公告乃由通用環球醫療集團有限公司（「本公司」）根據香港聯合交易所有限公司證券上 市規則（「上市規則」）第13.09(2)(a)條及香港法例第571章證券及期貨條例第XIVA部內幕 消息條文（定義見上市規則）作出。 本公司的全資附屬公司中國環球租賃有限公司（「發行人」）已得到中國證券監督管理委員 會（「中證監」）批復核准，在中華人民共和國（「中國」）面向合格投資者公開發行本金 總額最高達人民幣 20 億元的境內可續期公司債，截至本公告日期剩餘額度為人民幣 6.5 億元。 該債券採用分期方式發行，本次債券（「本期公司債」）發行本金總額不超過人民幣 3 ...